Mary Sullivan
Primary Care · Germantown, TNNPI 1053735282
Payments from drug & device makers
Across 1,058 payments — averaging $108.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$74K
- Tandem Diabetes Care, Inc.$23K
- Medtronic$3K
- Novo Nordisk$3K
- Corcept Therapeutics$1K
- Lilly USA, LLC$1K
- plus $9K from 35 others
What the payments were for
- Consulting fees$4,9754%
- Speaking & faculty fees$75,64366%
- Travel & lodging$13,37512%
- Food & beverage$20,97718%
- Education$840%
- Gifts$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$52,415
- t:slim X2 Insulin Pump with Control-IQ$22,488
- FreeStyle Libre 2$7,867
- FreeStyle Libre Pro$6,093
- FreeStyle Libre$4,970
- Minimed 770G System$1,875
- MINIMED 780G$1,060
- Korlym$476
- CeQur Simplicity$375
- Omnipod$248
- Kerendia$239
- AFREZZA$157
- DEXCOM G7 GSS (161)$128
- RECORLEV$120
- CRYSVITA$113
- FARXIGA$105
- TZIELD$101
- Ozempic$101
How this compares
$115,113 in reported general payments places this provider in the 95th percentile of 189 primary care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 184 | $213,675 |
| MounjaroTirzepatide | 142 | $187,507 |
| Humalog Kwikpen U-200Insulin Lispro | 19 | $56,864 |
| JardianceEmpagliflozin | 47 | $51,267 |
| Tresiba Flextouch U-200Insulin Degludec | 32 | $39,133 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 34 | $32,972 |
| FarxigaDapagliflozin Propanediol | 24 | $22,335 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $21,182 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 17 | $20,430 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 23 | $20,316 |
| JanuviaSitagliptin Phosphate | 26 | $20,077 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $18,870 |
| Tresiba Flextouch U-100Insulin Degludec | 21 | $18,833 |
| TrulicityDulaglutide | 12 | $18,517 |
| Humalog Kwikpen U-100Insulin Lispro | 47 | $16,550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Novolog | $2,756 | $224,213216 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,373 | $223,086218 claims |
| Boehringer IngelheimJardiance, Synjardy Xr | $534 | $65,75267 claims |
| AstraZenecaFarxiga | $245 | $22,33524 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $508 | $20,31623 claims |
| MerckJanuvia | $146 | $20,07726 claims |
| BayerKerendia | $604 | $9,00114 claims |
| AbbVieSynthroid | $1,146 | $3,10647 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $51 | $1,682133 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 189 primary care providers in Tennessee.
Other primary care in Germantown
- Lisa FrenzelGermantown$3K
- Len GetzMemphis$25K
- Judith CaldwellNashville$18K
- Mara HutchingsNashville$14K
- Reena BhaktaMurfreesboro$12K
- Ryan HartmanNashville$11K
- Martha LemonsBrentwood$11K
- Abigail EubankHendersonville$9K
- Corey ClelandSevierville$9K
- Katie JohnsonClarksville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.